Flexible 3-D Electrochemical Impedance Spectroscopy Sensors Incorporating Phase Delay for Comprehensive Characterization of Atherosclerosis

Michael Chen, Natalia Neverova, Shili Xu, Krit Suwannaphoom, Gentian Lluri, Mikayla Tamboline, Sandra Duarte, Michael C. Fishbein, Yuan Luo, René R. Sevag PackardbioRxiv 2023 · DOI

TL;DR

This paper introduces a novel 3D electrochemical impedance spectroscopy (EIS) sensor that can simultaneously assess both the structural (plaque burden) and compositional (inflammatory activity) aspects of atherosclerosis. This integrated approach offers a more comprehensive characterization of atherosclerotic lesions than current methods, potentially leading to better clinical management of coronary artery disease.

What Problem Does This Paper Address?

Atherosclerosis, the buildup of plaque in arteries, is a leading cause of death. Distinguishing between stable and rupture-prone (vulnerable) plaques is crucial for predicting adverse cardiovascular events. Current imaging techniques, both invasive and non-invasive, often require multiple modalities to capture different aspects of plaque. For example, intravascular ultrasound (IVUS) excels at visualizing plaque burden and calcification but struggles with compositional analysis. Positron Emission Tomography (PET) can detect inflammatory markers like macrophage infiltration, but it has limitations in spatial resolution and can be non-specific. This paper aims to develop a single, invasive imaging modality that can provide a more complete picture of atherosclerotic lesions by integrating structural and compositional information.

Methods

The researchers developed a flexible, 3D EIS sensor mounted on an inflatable balloon catheter. This sensor uses 6 points of contact to achieve 360° interrogation of the arterial wall, allowing for the capture of eccentric plaque formations. The EIS technique measures the electrical impedance and phase delay of tissues when subjected to an alternating current across a range of frequencies.

Key methodological aspects include:

  • 3D EIS Sensor: A novel 6-point sensor design for comprehensive circumferential assessment.
  • In Vivo Measurements: EIS was performed in New Zealand White rabbits that were fed a high-fat diet for 4 or 8 weeks, with or without balloon-induced endothelial injury to induce atherosclerosis.
  • Multi-Modal Comparison: EIS results were compared with established imaging techniques:
  • Intravascular Ultrasound (IVUS): For plaque burden and stenosis assessment.
  • Micro-PET/CT Imaging: Using radiotracers like 68Ga-DOTATATE (for macrophage presence), 18F-NaF (for microcalcification), and 18F-FDG (for metabolic activity).
  • Histology: For detailed analysis of plaque composition (macrophage infiltration, smooth muscle cell content, etc.).
  • Data Analysis: Specific signal processing techniques like background subtraction correction (BSC) were applied to EIS data. Correlations between EIS metrics and histological parameters were analyzed using Pearson correlation coefficients.

Datasets

The study utilized data from 16 male New Zealand White rabbits. These rabbits were divided into four groups based on diet duration (4 or 8 weeks) and the presence or absence of balloon injury, creating varying degrees of experimentally induced atherosclerosis. The data collected included blood work, micro-PET/CT imaging, IVUS, EIS measurements, and histological analysis of aortic tissue. No new benchmark datasets were introduced; rather, the study used established animal models and imaging modalities for comparison.

Key Insights and Ideas

  • EIS Phase Delay as a Structural Marker: The study found that EIS phase delay strongly correlates with anatomical markers of plaque burden, such as intima/media ratio and %stenosis, similar to IVUS. This suggests phase delay can effectively characterize the structural changes in atherosclerotic lesions.
  • EIS Impedance as a Compositional Marker: EIS impedance, on the other hand, showed significant correlations with markers of plaque activity and composition, specifically macrophage infiltration and the macrophage/smooth muscle cell (SMC) ratio. This indicates impedance can reveal the inflammatory and cellular makeup of the plaque.
  • Integrated Characterization: The core idea is that EIS, by measuring both impedance and phase delay, can provide a unified assessment of both the "anatomy" (plaque burden) and "activity" (inflammation) of atherosclerosis, which typically requires multiple imaging modalities.
  • Specificity of PET Tracers: The study highlighted the specificity of 68Ga-DOTATATE for macrophage infiltration, correlating well with histological findings, whereas 18F-FDG showed less specificity due to uptake by other cell types.

Key Results

  • Phase Delay: Correlated strongly with intima/media ratio (r=0.883 at 1 kHz) and %stenosis (r=0.901 at 0.25 kHz).
  • Impedance: Correlated with macrophage infiltration (r=0.813 at 10 kHz) and macrophage/SMC ratio (r=0.813 at 25 kHz).
  • PET Tracer Correlations: 68Ga-DOTATATE showed strong correlations with intimal macrophage infiltration (r=0.861) and macrophage/SMC ratio (r=0.831). 18F-NaF correlated with SMC infiltration (r=-0.842), and 18F-FDG correlated with macrophage/SMC ratio (r=0.787).
  • IVUS Correlations: Plaque burden determined by IVUS correlated significantly with intima/media ratio (r=0.939) and %stenosis (r=0.892).
  • Catheter Stability: EIS measurements were found to be consistent across different catheter designs, indicating reliability.

Limitations and Future Work

  • Animal Model: The study used experimentally induced atherosclerotic lesions in rabbits, which may not perfectly represent human lesions. Future research should assess the applicability of serial EIS measurements in humans.
  • Single Timepoint: EIS measurements were taken at one timepoint (animal euthanasia). Serial measurements over time would provide insights into the progression of atherosclerosis.
  • Clinical Translation: The authors posit that their results lay the foundation for invasive EIS interrogation in human atherosclerotic lesions and the determination of clinically relevant threshold values for impedance and phase delay to guide revascularization decisions. Future work should focus on translating these findings to clinical practice.

Summary updated

Abstract

Electrochemical impedance spectroscopy (EIS) characterizes both anatomic features - via phase delay; and inflammatory activity - via impedance profiles, of underlying atherosclerosis.EIS can serve as an integrated, comprehensive metric for atherosclerosis evaluation by capturing morphological and compositional plaque characteristics that otherwise require multiple imaging modalities to obtain.Translation of these findings from animal models to human coronary artery disease may provide an additional strategy to help guide clinical management.
BibTeX
@misc{chen2023flexible,
  author = {Michael Chen and Natalia Neverova and Shili Xu and Krit Suwannaphoom and Gentian Lluri and Mikayla Tamboline and Sandra Duarte and Michael C. Fishbein and Yuan Luo and René R. Sevag Packard},
  title = {{Flexible 3-D Electrochemical Impedance Spectroscopy Sensors Incorporating Phase Delay for Comprehensive Characterization of Atherosclerosis}},
  year = {2023},
  doi = {10.1101/2023.09.20.558681},
  howpublished = {bioRxiv},
}
Figure